Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Sequencer As A Service Market Growth From $2.76 Billion In 2026 To $5.73 Billion By 2030 At A CAGR Of 20%
The sequencer as a service market has experienced swift expansion in recent years. This market is anticipated to increase its value from $2.31 billion in 2025 to $2.76 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 19.8%. The historical growth can be attributed to several factors, including the escalating demand for genomic research, restricted access to in-house sequencing platforms, the significant expense of sequencing instruments, the proliferation of personalized medicine initiatives, and enhanced collaborations between research institutes and sequencing providers.
The sequencer as a service market is anticipated to undergo significant expansion in the coming years. It is projected to achieve a valuation of $5.73 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 20.0%. The expansion during the forecast period is propelled by the increasing acceptance of cloud-based sequencing solutions, the growing need for high-throughput sequencing services, the integration of AI-driven bioinformatics analysis, the broader application of clinical genomics, and the rise in outsourcing of sequencing tasks. Noteworthy trends for the forecast period involve cloud-based sequencing services, automated sample preparation, cohesive bioinformatics solutions, pay-per-use sequencing frameworks, and scalable genomic data management.
Get A Free Sample Report With In-Depth Market Insights:
Sequencer As A Service Market Growth Catalysts And Demand Drivers
The anticipated expansion of the sequencer as a service market is significantly driven by the rising occurrence of genetic disorders. These medical conditions stem from anomalies in an individual’s deoxyribonucleic acid, which can be inherited from either parent or emerge from new mutations. The heightened incidence of genetic disorders is partly attributed to increasing parental age, given that older parents face a greater likelihood of transmitting genetic mutations to their offspring. Sequencer as a service offers a solution to genetic disorders by enabling scalable, on-demand access to sophisticated DNA and RNA sequencing technologies, facilitating prompt detection and precise diagnosis. This service alleviates infrastructure and operational complexities for laboratories and healthcare entities by providing cloud-based data analysis and specialized support, thereby enhancing precision medicine outcomes and research productivity. For example, data from May 2024, released by the UK’s National Health Service, indicated that 17,000 individuals are affected by sickle cell disease, an inherited genetic blood disorder, with approximately 250 new diagnoses annually. Consequently, the expanding prevalence of genetic disorders is a primary catalyst for the growth of the sequencer as a service market.
Sequencer As A Service Market Segment Breakdown: Which Categories Lead On Revenue?
The sequencer as a service market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Service Type: Sample Preparation Services, Library Preparation Services, Sequencing Execution Services, Bioinformatics Analysis Services, Data Storage And Management Services, Integrated End-to-End Sequencing Services
3) By Deployment Mode: Cloud-Based, On-Premises
4) By Application: Clinical Diagnostics, Oncology Research, Rare Disease Research, Infectious Disease Surveillance, Drug Discovery And Development, Agrigenomics, Forensic Genomics, Reproductive Health Testing, Personalized Medicine Research
5) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Academic Institutions, Other End Users
Subsegments:
1) By Software: Bioinformatics Analysis Platforms, Sequence Data Management Systems, Variant Interpretation Tools, Workflow Automation Software, Cloud-Based Data Processing Platforms
2) By Hardware: High Throughput Sequencing Instruments, Sample Preparation Systems, Laboratory Automation Equipment, Data Storage Servers, High Performance Computing Infrastructure
3) By Services: Sample Processing Services, Library Preparation Services, Sequencing Execution Services, Bioinformatics Interpretation Services, Data Storage And Management Services, Consulting And Technical Support Services
Sequencer As A Service Market Trends Shaping Long-Term Demand
Leading firms in the sequencer as a service market are prioritizing the integration of artificial intelligence-driven bioinformatics platforms, specifically the certified provider accreditation initiative, to elevate service quality, ensure technical adherence, and streamline workflow standardization across various genomics and single-cell analysis applications. The certified provider accreditation initiative itself is a structured framework where an entity officially acknowledges and licenses external service providers or collaborators that fulfill specified criteria for technical skill, operational excellence, and regulatory compliance. An illustrative example occurred in July 2024, when Parse Biosciences, a Seattle-based company specializing in single-cell sequencing solutions, unveiled its Certified Service Provider Program aimed at expanding the availability of scalable single-cell analysis. This program facilitates collaboration between researchers and accredited providers like SeqMatic and Eurofins Clinical Enterprise, who offer comprehensive, end-to-end workflows covering solutions such as Evercode Whole Transcriptome, Evercode TCR, CRISPR Detect, Gene Capture, and Evercode BCR, thereby enabling high-throughput capture of full-length BCR sequences alongside gene expression. This commitment guarantees proficient sample management, consistent workflow practices, and superior quality outcomes, positioning it as an optimal solution for both initial pilot studies and regular large-scale single-cell endeavors.
Sequencer As A Service Market Leading Players And Competitive Positioning
Major companies operating in the sequencer as a service market are Admera Health, ArrayGen Technologies, BGI Genomics Co. Ltd., CD Genomics Inc., Element Biosciences, Eurofins Scientific SE, Gene by Gene, GENEWIZ Germany GmbH, Illumina Inc., Karkinos Healthcare, Lucigen, Macrogen Inc., MedGenome Labs Ltd., Novogene Co. Ltd., Quest Diagnostics, SeqMatic LLC, SeqWell, Strand Life Sciences Pvt. Ltd., Veritas Genetics, Yaazh Xenomics.
View The Full Sequencer As A Service Market Report:
Sequencer As A Service Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the sequencer as a service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sequencer as a service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
